Novo Nordisk A/S Dividend History (NVO)
🤑 Novo Nordisk A/S has distributed a total of 31 dividends from 2003 to 2024
📉 During this 21 period their dividend has seen a -1.14% decrease in the payout amount
About Novo Nordisk A/S
Novo Nordisk A/S is a renowned global healthcare company anchored in Denmark, primarily known for its leadership in diabetes care. Founded in 1923 through the merger of two Danish companies, Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium, the company has grown into one of the world’s largest producers of insulin. Novo Nordisk is dedicated to driving change in diabetes treatment with a wide spectrum of products ranging from insulin medications to systems for diabetes management. Besides diabetes care, the company is actively involved in research and development for other serious chronic conditions such as obesity, hemophilia, and growth disorders. With over 100 years in operation, Novo Nordisk is a key player in global health and innovation in the pharmaceutical industry. The company continues to thrive with significant revenues, reflecting its impact and presence in over 170 countries worldwide.
Apple Inc.
Microsoft Corporation
Johnson & Johnson
Procter & Gamble Co.
Coca-Cola Co.
PepsiCo, Inc.
Exxon Mobil Corporation
Verizon Communications Inc.
AT&T Inc.
Chevron CorporationThe European Commission has approved Novo Holdings' acquisition of Catalent, a global contract development and manufacturing organization, as well as Novo Nordisk's subsequent acquisition of three manufacturing sites from Novo Holdings.
GlobeNewswire Inc. · Published on Fri Dec 06 2024
Billionaire Izzy Englander has increased his hedge fund's stake in Eli Lilly, a pharmaceutical company that produces obesity and diabetes drugs. Wall Street analysts are generally positive on Lilly's prospects, citing the strong performance of its drugs Zepbound and Mounjaro.
The Motley Fool · Published on Fri Dec 06 2024
Eli Lilly's weight loss drug Zepabound outperformed Novo Nordisk's Wegovy in a clinical trial, setting the stage for Lilly to gain market share in the growing GLP-1 weight loss drug market.
Investing.com · Published on Thu Dec 05 2024Previous Payouts (31)
The most recent dividend Novo Nordisk A/S paid out was on August 26, 2024 (106 days ago) for $0.5169016 per share
| Pay Date | Amount |
|---|---|
| August 26, 2024 | $0.5169016 |
| April 2, 2024 | $0.9293348 |
| August 29, 2023 | $0.8763389 |
| April 4, 2023 | $1.1805812 |
| August 23, 2022 | $0.5777452 |
| April 5, 2022 | $1.022423 |
| August 25, 2021 | $0.5502889 |
| April 7, 2021 | $0.922122 |
| August 25, 2020 | $0.5177774 |
| April 7, 2020 | $0.7826048 |
| August 27, 2019 | $0.449438 |
| April 2, 2019 | $0.777006 |
| August 28, 2018 | $0.462327 |
| April 3, 2018 | $0.805982 |
| August 29, 2017 | $0.473821 |
| April 4, 2017 | $0.670368 |
| August 23, 2016 | $0.453459 |
| March 30, 2016 | $0.958141 |
| March 31, 2015 | $0.72998 |
| April 2, 2014 | $0.830304 |
| April 2, 2013 | $3.10179 |
| April 3, 2012 | $2.509455 |
| April 5, 2011 | $1.885974 |
| April 7, 2010 | $1.359188 |
| March 31, 2009 | $1.085462 |
| March 25, 2008 | $0.942309 |
| March 20, 2007 | $1.238582 |
| March 21, 2006 | $0.960768 |
| March 22, 2005 | $0.85729 |
| March 29, 2004 | $0.72356 |
| April 7, 2003 | $0.52287 |
Dividend data last updated Mon, 09 Dec 2024 14:33:33 GMT UTC